Editor’s note: Pancreatic Cancer Action Network (PanCAN) President and CEO Julie Fleshman attended the Harvard Business School (HBS) Kraft Precision […]
READ MORE
Precision PromiseSM Clinical Trial Consortium Sites
Precision Promise will launch across Clinical Trial Consortium sites that have been selected throughout the country.

Cedars-Sinai Medical Center (Los Angeles, CA)
Principal investigator: Andrew Hendifar, MD
Dana Farber/Harvard Cancer Center (Boston, MA)
Principal investigator: Brian Wolpin, MD, MPH
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance/University of Washington (Seattle, WA)
Principal investigator: Sunil Hingorani, MD, PhD
Johns Hopkins (Baltimore, MD)
Principal Investigator: Daniel Laheru, MD
MD Anderson (Houston, TX)
Principal Investigator: Milind Javle, MD
Memorial Sloan Kettering Cancer Center (New York, NY)
Principal investigator: Eileen O’Reilly, MD
Perlmutter Cancer Center/NYU Langone Health (New York, NY)
Principal investigator: Diane Simeone, MD
University of California, San Diego (San Diego, CA)
Principal investigator: Andrew Lowy, MD
University of California, San Francisco (San Francisco, CA)
Principal investigator: Andrew Ko, MD
University of Chicago (Chicago, IL)
Principal investigator: Hedy Kindler, MD
University of Florida (Gainesville, FL)
Principal investigator: Thomas George, MD, FACP
University of Pennsylvania (Philadelphia, PA)
Principal investigator: Gregory Beatty, MD, PhD
Virginia Mason Medical Center (Seattle, WA)
Principal investigator: Vincent Picozzi, MD
Washington University (St. Louis, MO)
Principal investigator: Andrea Wang-Gillam, MD, PhD
Other Relevant Topics: